What's in Synairgen Research Ltd.'s pipeline?

Synairgen Research Ltd. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Synairgen Research Ltd.'s portfolio?

Top competitors by shared drug class: Bayer, Biogen, Case Comprehensive Cancer Center, Celgene, Cinnagen.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/synairgen-research-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Synairgen Research Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Synairgen Research Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
SNG001	SNG001	phase 3	Interferon	IFNAR	Respiratory

Therapeutic area mix

Respiratory · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
Biogen · 1 shared drug class
Case Comprehensive Cancer Center · 1 shared drug class
Celgene · 1 shared drug class
Cinnagen · 1 shared drug class
EMD Serono · 1 shared drug class
EMD Serono Research & Development Institute, Inc. · 1 shared drug class
Active Biotech AB · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Synairgen Research Ltd.:

Cite this brief

Drug Landscape (2026). Synairgen Research Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/synairgen-research-ltd. Accessed 2026-06-10.